Mean |
| ||||
Evaluation items | Number of patients | Baseline | LOCFa) | (LOCFa)-Baseline) | Analysisb) |
DTSQsa) | |||||
Treatment satisfaction (Sum of Questions 1, 4-8) | 856 | 21.9 | 25.5 | 3.6 | p < 0.0001 |
Perceived frequency of hyperglycaemia (Question 2) | 890 | 3.9 | 2.7 | −1.1 | p < 0.0001 |
Perceived frequency of hypoglycaemia (Question 3) | 884 | 1.0 | 1.4 | 0.4 | p < 0.0001 |
DTSQca) | |||||
Change in treatment satisfaction (Sum of Questions 1, 4-8) | 978 | - | 9.3 | - | p < 0.0001 |
Change in perceived frequency of hyperglycaemia (Question 2) | 987 | - | −0.2 | - | p < 0.0001 |
Change in perceived frequency of hypoglycaemia (Question 3) | 984 | - | −0.5 | - | p < 0.0001 |
EQ-5Da) and EQ-VASa) | |||||
EQ-5D Index score | 856 | 0.890 | 0.909 | 0.019 | p = 0.0005 |
EQ-VAS score | 879 | 61.5 | 69.4 | 7.8 | p < 0.0001 |